Biliary Tract Cancers (BTCs) Market is segmented By Treatment (Chemotherapy (Platinum-based Agents, Fluoropyrimidines, Gemcitabine), Targeted Therapy (Tyrosine Kinase Inhibitors, FGFR Inhibitors), Immunotherapy (PD-1/PD-L1 Inhibitors, Radiation Therapy)), By Cancer Type (Intrahepatic Bile Duct Cancer, Extrahepatic Bile Duct Cancer, Gallbladder Cancer), By Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.